Tissue Factor–Factor VII Complex as a Key Regulator of Ovarian Cancer Phenotypes

Biomarkers in Cancer
doi 10.4137/bic.s29318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Tissue Factor Expression in Ovarian Cancer: Implications for Immunotherapy With hI-con1, a Factor VII-IgGFc Chimeric Protein Targeting Tissue Factor

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2011English

Factor VII Light Chain-Targeted Lidamycin Targets Tissue Factor-Overexpressing Tumor Cells for Cancer Therapy

International Journal of Molecular Medicine
MedicineGenetics
2011English

Daily and Circadian Rhythms of Tissue Factor Pathway Inhibitor and Factor VII Activity

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2005English

Diet and Blood Coagulation Factor VII—a Key Protein in Arterial Thrombosis

European Journal of Clinical Nutrition
MedicineNutritionDietetics
1998English

Glucose as a Prognostic Factor in Ovarian Carcinoma

Cancer
Cancer ResearchOncology
2009English

SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer

PLoS ONE
Multidisciplinary
2012English

Addressee as a Key Factor of Courtroom Discourse Production

SHS Web of Conferences
2019English

Persistent Descending Mesocolon as a Key Risk Factor in Laparoscopic Colorectal Cancer Surgery

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy